ICICI Securities Recommends Buying Archean Chemical Industries, Sets Rs 620 Target

ICICI Securities says Archean Chemical’s Q2FY27 EBITDA rose 12.1% year over year, helped by higher bromine contribution, while higher logistics and input costs weighed on salt-business profits. Bromine volumes increased but were affected by [truncated].